• Christine Shi Min Chau, Samuel Cheng En Ee, Xiaoting Huang, Wei Shyan Siow, Michelle Bee Hua Tan, Sarah Kher Ru Sim, Ting Yu Chang, Kah Meng Kwok, Kangqi Ng, Li Fang Yeo, Aileen Lim, Lydia Euphemia Sim, Simon Conroy, and Barbara Helen Rosario.
• Department of Geriatric Medicine, Changi General Hospital, Singapore.
• Ann Acad Med Singap. 2024 Feb 28; 53 (2): 9010090-100.

IntroductionFrailty has an important impact on the health outcomes of older patients, and frailty screening is recommended as part of perioperative evaluation. The Hospital Frailty Risk Score (HFRS) is a validated tool that highlights frailty risk using 109 International Classification of Diseases, 10th revision (ICD-10) codes. In this study, we aim to compare HFRS to the Charlson Comorbidity Index (CCI) and validate HFRS as a predictor of adverse outcomes in Asian patients admitted to surgical services.MethodA retrospective study of electronic health records (EHR) was undertaken in patients aged 65 years and above who were discharged from surgical services between 1 April 2022 to 31 July 2022. Patients were stratified into low (HFRS <5), interme-diate (HFRS 5-15) and high (HFRS >15) risk of frailty.ResultsThose at high risk of frailty were older and more likely to be men. They were also likely to have more comorbidities and a higher CCI than those at low risk of frailty. High HFRS scores were associated with an increased risk of adverse outcomes, such as mortality, hospital length of stay (LOS) and 30-day readmission. When used in combination with CCI, there was better prediction of mortality at 90 and 270 days, and 30-day readmission.ConclusionTo our knowledge, this is the first validation of HFRS in Singapore in surgical patients and confirms that high-risk HFRS predicts long LOS (≥7days), increased unplanned hospital readmissions (both 30-day and 270-day) and increased mortality (inpatient, 10-day, 30-day, 90-day, 270-day) compared with those at low risk of frailty.

33 keywords...

hide…